1832 Asset Management L.P. Horizon Therapeutics Public LTD CO Transaction History

1832 Asset Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $122 Million - $154 Million	-1,406,500 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$98.56 - $119.91 $130 Million - $158 Million	1,318,180 Added 1492.5%	1,406,500 $152 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $8.12 Million - $9.75 Million	88,320 New	88,320 $9.76 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.